China has said that it is actively considering establishing a BRICS innovation base to strengthen practical cooperation with the five-member bloc, urging it to focus more on digital transformation, especially in 5G, Artificial Intelligence and the digital economy in the post-COVID-19 era.
China is vigorously promoting the resumption of work across the entire industry chain, and is keen to see more development in new industries such as 5G, AI and the industrial Internet during the COVID-19 pandemic, Minister of Industry and Information Technology Xiao Yaqing said during a video meeting of the BRICS industry ministers on Monday.
The meeting adopted a joint statement on cooperation in new industries among BRICS (Brazil, Russia, India, China and South Africa) countries, state-run media reported on Tuesday.
China is actively considering the establishment of a BRICS innovation base in the country in order to strengthen practical cooperation with the BRICS bloc, Xiao said.
He urged the BRICS countries to strengthen their cooperation on digital transformation, especially in 5G, AI, the digital economy and others to promote the digital transformation of enterprises and their innovation capabilities, and to promote sustainable economic and social development.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
"At present, growth in China's industrial economy is gaining momentum, in turn supporting the steady recovery of China's overall economy, and contributing to a new impetus and stability in the global industrial chain and supply chain," Xiao said.
China is committed to ensuring the production and supply of key medical materials, meeting China's domestic epidemic prevention and control needs, and providing a large amount of material assistance to countries around the world to fight against the pandemic.
"BRICS countries should cooperate to promote economic recovery, strengthen communication and sharing their experiences in epidemic prevention and control, guarantee medical supplies, resume work and production, and promote economic development during COVID-19,” he said.
Xiao urged BRICS countries to strengthen the industrial chain and supply chain, enhance development resilience and the countries' abilities to respond to risks, and jointly create a good development environment, he added.
According to a tally by Johns Hopkins University, more than 813,000 people have died of COVID-19 which has infected 23,676,599 globally.Nearly 5.7 million cases have been reported in the US, making America the worst-hit country in the world after the disease emerged in the central Chinese city of Wuhan last year.